newsfilter
← Latest News
GlobeNewswire·

NervGen to Host Inaugural R&D Day on September 30, 2026

R&D Day to feature an in-depth review of NVG-291, including its nonclinical and translational foundation, broader therapeutic potential, clinical data generated to date, perspectives from the SCI community, and the